Hosted on MSN1h
Semaglutide's cardiovascular benefits are maintained in people with impaired kidney function, research finds
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don ...
People Taking Semaglutide Appear to Be WAY Less Likely to Die of an Opioid Overdose
Medical researchers have found that people who take the semaglutide-based drugs Ozempic and Wegovy may be less likely to die ...
Let’s talk about semaglutide — is it safe, and who should consider it?
Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...
Medscape4d
Semaglutide a Potential Treatment Option for Opioid Use Disorder?
Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...
Neurology Advisor20h
Semaglutide May Lower Risk for Opioid Overdose in T2DM, Opioid Use Disorder
For patients with type 2 diabetes and opioid use disorder, semaglutide is associated with a significantly lower risk for opioid overdose.
News Medical10d
How Does Semaglutide Work to Lose Weight?
Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...
Science News5d
Semaglutide may reduce opioid overdoses, a new study suggests
A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.
Semaglutide improves outcomes for obese patients with common skin condition, new study shows
A pioneering study, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the ...
Medscape12d
Combining Semaglutide and Mineralocorticoids May Improve CKD
MADRID — The benefits of semaglutide treatment in reducing kidney disease, cardiovascular, and mortality risks in people ...